Liz Hockley

Articles by Liz Hockley

Europe

UPC orders Sanofi to fix ‘deficiencies’ in prostate cancer drug case

Munich division asks pharma company for clarity on territorial scope | Sanofi took battle with four generic makers over Jevtana to UPC.   28 January 2025

Careers

Munck Wilson Mandala brings in first-chair patent litigator from McGuireWoods

Firm adds partner to Houston office with expertise in biotechnology and complex patent litigation.   28 January 2025

Unified Patent Court

IP Federation warns against ‘blanket ban’ on in-house counsel at UPC

UK trade association weighs in on Microsoft UPC appeal which deals with issue of representation | Former CIPA head says court should not “divide” European patent profession | SMEs could be forced to opt out patents due to counsel costs.   21 January 2025

Careers

Maucher Jenkins lands nine-strong team from rival boutique

Partner plus team of four patent attorneys and four paralegals join Munich office | Firm says the addition strengthens its position in German and international markets.   16 January 2025

Europe

EPO report reveals leading tech investors in Europe

New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes.   16 January 2025

Pharma

Novartis wins appeal in MSN clash over heart drug generic

Federal circuit reverses district court’s ruling to revive combination patent | Novartis says patent has paediatric exclusivity expiring in July 2025.   14 January 2025

Americas

Medtech firm strikes out part of Apple button patent in ECG row

PTAB determines all but one of challenged claims unpatentable | Decision is latest instalment in clash over electrocardiogram technology | Apple bid to stop ‘AliveCor’s rampant infringement’ backfires.   9 January 2025

Europe

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

Paris Local Division revokes Dexcom patent and dismisses infringement action against rival | UPC revoked two other patents belonging to medical device company earlier in 2024.   12 December 2024

Americas

Judge denies Intellia bid to throw out suit over $100m Regeneron pact

BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using innovation to research therapeutic candidates.   10 December 2024

Americas

EOFlow ordered to pay rival $452m over insulin patch trade secrets

Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.   5 December 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.